In conclusion, our study reveals that STAT1 is a sumoylation substrate of RanBP2, and that RanBP2 facilitates viral infection by attenuating interferon-α-induced antiviral innate immunity, likely by sumoylating STAT1. This evidence concerns the gene RANBP2 and viral infectious disease.